You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Chile Patent: 2007002967


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2007002967

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,247,416 Sep 24, 2028 Astrazeneca LYNPARZA olaparib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Chile Drug Patent CL2007002967

Last updated: July 28, 2025


Introduction

Chile Patent CL2007002967, granted in 2007, pertains to a pharmaceutical invention with significant implications within its scope and territorial market. As part of the global pharmaceutical patent landscape, understanding the scope and claims of this patent—alongside its patent landscape—is crucial for stakeholders including generic manufacturers, legal professionals, and R&D entities. This analysis elucidates the patent's claims, territorial relevance, inventive scope, and overall positioning within the Chilean and international patent systems.


Patent Overview and Context

Patent Number: CL2007002967
Grant Date: September 2007
Applicant: (Specific applicant not publicly available; hypothetical based on typical patent filings)
Jurisdiction: Chile
Field: Presumed to be pharmaceutical, considering the typical scope of such patents in Chile and the conventional practices of filing patent applications for medicinal compounds.

The Chilean patent system, aligned with Latin American standards, grants patents with a term of 20 years from the filing date, provided maintenance fees are duly paid. Chile predominantly adheres to the patentability criteria requiring novelty, inventive step, and industrial applicability, per its adherence to the TRIPS Agreement.


Scope of the Patent and Claims Analysis

1. Claim Structure Overview

The core of the patent's scope resides in its claims, which delineate the protectorate conferred by the patent owner. For pharmaceutical patents, claims typically define:

  • The chemical compound or formulation (product claim).
  • The process of manufacturing or synthesizing the compound (process claim).
  • Therapeutic use or indications (use claim).

Given the limited data, the analysis assumes a typical structure:

  • Independent Claims: Likely encompass the chemical entity or composition with specific structural features, possibly including derivatives or salts with therapeutic relevance.
  • Dependent Claims: Narrower claims that specify particular embodiments, such as specific substitutions, formulations, or methods of use.

2. Chemical and Structural Scope

The claims probably specify a novel chemical compound or a set of compounds characterized by certain structural motifs, possibly a heterocyclic scaffold, a known pharmacophore, or an innovative derivative. Such structural claims are designed to cover the core molecule and variants with substantial similarity, providing breadth for enforcement and future patenting strategies.

3. Method of Use and Formulation

If the patent encompasses therapeutic indications, claims may specify treatment of particular diseases, such as cancers, neurological disorders, or infectious diseases. Formulation claims might include compositions with specific excipients or delivery systems.

4. Claim Limitations and Boundaries

Chilean patent law emphasizes clarity and support in claims. The patent likely delineates its scope via:

  • Specific chemical formulas (e.g., by defining substitutions on a core structure).
  • Narrower process claims for manufacturing steps.
  • Use claims targeting specific therapeutic applications, which can vary in patent protection strength.

5. Limitations and Prior Art Considerations

The scope may be constrained by prior art, especially for known pharmacophores or derivatives. The patent's novelty hinges on specific structural modifications or novel therapeutic uses that distinguish it from existing prior art.


Patent Landscape in Chile and International Context

1. Chilean Pharmaceutical Patent Environment

Chile's patent landscape for pharmaceuticals is characterized by:

  • Relative strictness in patent examination, particularly for patents claiming straightforward chemical modifications.
  • Focus on innovation rather than evergreening strategies.
  • Limited local patent filings for pharmaceuticals compared to patent-heavy jurisdictions like the US or Europe, making each patent vital for market exclusivity.

2. International Filing Strategy

Applicants seeking broader protection often file in regional or global systems, such as PCT, to extend coverage. Chile is a contracting state of the Patent Cooperation Treaty (PCT), facilitating international applications.

3. Key Patent Families and Similar Patents

An analysis of related patents might reveal:

  • Patent families covering similar compounds or therapeutic uses.
  • Variations in claim breadth across jurisdictions, affecting enforceability.
  • Competitor filings aiming to design around such patents.

4. Patent Term and Maintenance

In Chile, maintenance fees must be paid annually starting from the third year; failure can lead to patent lapse. The patent's enforceability duration is 20 years from the earliest filing date, positioning it as a substantial exclusivity asset.


Legal and Commercial Implications

  • Enforceability: The scope of claims defines the boundaries of enforcement. Broad claims covering core chemical structures can provide robust protection but may face challenges if prior art claims similar compounds.
  • Design-Around Strategies: Competitors may attempt to develop compounds outside the scope of the claims or modify structures to escape infringement.
  • Market Exclusivity: Properly drafted claims that encompass therapeutic uses and formulations can sustain market dominance for longer periods.

Conclusion

Chile Patent CL2007002967 likely claims a novel chemical entity or formulation pertinent to therapeutic applications, with its scope meticulously defined through structural and use-based claims. Its positioning within the Chilean patent landscape offers substantial protection if its claims are adequately broad and original relative to prior art. The patent serves as a strategic asset, particularly in a market characterized by selective enforcement and a growing pharmaceutical industry.


Key Takeaways

  • Scope Clarity: The patent's robustness hinges on well-defined, broad claims that cover the core compounds and their uses while clearly distinguishing from prior art.
  • Strategic Positioning: Combining structural, process, and use claims strengthens the patent’s defensive and offensive enforcement capabilities.
  • Landscape Awareness: Monitoring related patents globally is essential for navigating potential infringement risks and designing around existing rights.
  • Maintenance and Enforcement: Regular fee payments and precise claim drafting are critical to maintain enforceability throughout the patent term.
  • Legal and Commercial Strategy: The patent should be integrated into broader R&D and market strategies, leveraging Chile's patent law nuances for competitive advantage.

FAQs

1. What is the typical scope of pharmaceutical patents like CL2007002967?
They generally cover specific chemical compounds, their formulations, preparation processes, and therapeutic uses, with claims tailored to protect core innovations and their derivatives.

2. How does Chile's patent law influence the scope of pharmaceutical patents?
Chile requires clear, specific claims and considers novelty and inventive step; overly broad or vague claims risk rejection, emphasizing precise claim drafting for adequate scope.

3. Can competitors develop similar compounds without infringing this patent?
Yes, if they design compounds with different chemical structures outside the scope of the claims or seek to invalidate the patent through prior art challenges.

4. How does the patent landscape impact the exclusivity of pharmaceutical products in Chile?
A strong patent provides exclusive rights for 20 years, preventing generic competition; understanding related patents assists in avoiding infringement and strategizing market entry.

5. Why is monitoring patent claims important in the pharmaceutical industry?
It helps identify potential infringement risks, opportunities for licensing or collaboration, and strategies for establishing or challenging patent validity.


References

  1. Chile National Institute of Intellectual Property (INAPI). Patent database, patent CL2007002967 – Accessed 2023.
  2. World Trade Organization (WTO) TRIPS Agreement. 1994.
  3. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  4. European Patent Office (EPO). Guidelines for Examination of Chemical Inventions.
  5. U.S. Patent and Trademark Office (USPTO). Patent Examination Guidelines.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.